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Seminars in NephrologSummary: Volume management in peritoneal dialysis patients is of importance, as both volume overload and
dehydration are associated with worse outcomes. When assessing volume status, it is important to understand
that different techniques measure different fluid compartments (intracellular vs extracellular vs circulating
volume) and the impact of cardiac function. Attention to salt restriction and diuretics can help to maintain
euvolemia without need for hypertonic bags. Glycaemia should be monitored to avoid thirst. Dwell length
should be adapted to transport status: short dwells for fast transporters, long dwells in slow transporters. The
role of bio-compatible solutions on volume control remains controversial.
Semin Nephrol 37:43-53 C 2017 Elsevier Inc. All rights reserved.
Keywords: peritoneal dialysis, volume overload, bio-impedance, cardiac failureWhen discussing ﬂuid status in peritonealdialysis (PD) patients, it is important toremember that ﬂuid can accumulate in
different compartments. It is most important to make
a distinction between intracellular and extracellular
water, whereby the latter is to be divided in the
circulating and interstitial compartments. Intracellular
water (ICW) is associated directly and linearly with
muscle mass. In adipose tissue, the obligatory associ-
ated water is found mainly in the extracellular compart-
ment, which results in an increasing extracellular water
to total body water (ECW/TBW) ratio because fat mass
goes up in obese people, and this is irrespective of
hydration status. Fluid volume in the circulating
compartment is most relevant for direct cardiovascular
consequences, mainly hypertension and pulmonary
congestion. The causes and clinical consequences of
ﬂuid accumulation might be different between these
different compartments, and the method used to assess
the ﬂuid status also will impact which compartment
mainly is targeted and thus will inﬂuence the ﬁnal
results, explaining in part the poor correlation between
the different methods to assess volume status.1 It thus
is important to take into account which compartment
has been assessed when interpreting results or making
clinical decisions based on assessments of volume
status.
Evidence points out that in PD patients, ﬂuid
overload is present mostly in the extracellular non-
circulating compartment.2matter
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y, Vol 37, No 1, January 2017, pp 43–53It also is important to use consistent terminology
when talking about ﬂuid status of PD patients.3 Fluid
balance is the difference between the volume of
dialysis ﬂuid drained from and that instilled into
the patient. It should not be used to indicate the
absolute ﬂuid status/hydration status of the patient.
Overhydration, normohydration, and dehydration
should be used for qualitative descriptions of ﬂuid
status, whereas ﬂuid overload in liters is suitable to
quantify the amount of overhydration (positive num-
ber) or dehydration (negative number).3 Volume status
should be used only to qualitatively describe the ﬂuid
present in the circulating (plasma) compartment.EPIDEMIOLOGY OF FLUID STATUS IN PD
Fluid overload (FO), common in PD patients, is linked
directly to increased cardiovascular (CV) morbidity
and mortality. Congestive heart failure, which accounts
for approximately 5% of all-cause mortality in preva-
lent dialysis patients, is associated closely with ﬂuid
overload, although other major CV events also could
be affected by it.4 However, volume control is a
modiﬁable risk factor.5
Adequacy of peritoneal dialysis in Mexico (ADE-
MEX) showed no survival advantage of an increased
dose of small-molecule clearance delivered by PD, but
found an association of ﬂuid overload and mortality.6
All these have shifted the focus of dialysis adequacy
from small-solute clearance to volume control.7 The
International Society of Peritoneal Dialysis (ISPD)
guideline recommends regular clinical assessment of
hydration status. It also recommends that hypertensive
PD patients should have their volume status optimized
before starting an antihypertensive treatment.8
Fluid status in PD patients can be assessed in differ-
ent ways, and the prevalence of ﬂuid overload varies
depending on which method was used. The initiative for
patient outcomes in dialysis - peritoneal dialysis (IPOD-
PD) study of 1,092 patients from 135 centers in 32
countries investigated the baseline hydration status in43
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of patients was overhydrated already before the start of
PD. Symptomatic ﬂuid retention based on clinical signs
was noted in 25% of PD patients.9 Common clinical
manifestations included peripheral edema (100%), pul-
monary congestion (80%), pleural effusions (76%), and
systolic (83%) and diastolic (66%) hypertension.7 When
ﬂuid status was assessed using a bioimpedance spectro-
scopy device in a cross-sectional cohort (European
Body Composition Monitoring study (EuroBCM)
cohort) of prevalent PD patients in 6 European coun-
tries, only 40% of 639 patients were normovolemic,
with 25.2% being severely ﬂuid overloaded.10 By using
bioimpedance spectroscopy, ECW/TBW of 0.40 or
greater was found in 205 (66.8%) of 307 Chinese
chronic ambulatory PD (CAPD) patients.11 More than
a third (36.6%) of PD patients were overhydrated, but
without hypertension or other clinical signs, as assessed
by the 90th percentile of a cohort of age-matched kidney
transplantation patients.12 Fluid overload as determined
by bioimpedance spectroscopy (overhydration (OH)) of
1.5 L or more was detected in 60.5% of clinically stable
PD patients, with 73.1% being subclinical,13 whereas in
asymptomatic Chinese PD patients, 88 of 122 (72.1%)
had overhydration of 1 L or more and 25 (20.5%) had
5 L or more.14 Based on chest ultrasound, moderate to
severe lung congestion was detected in a signiﬁcant
proportion (46%) of asymptomatic PD patients (New
York Heart Association class I).15FLUID STATUS IN PD VERSUS HEMODIALYSIS
Peritoneal dialysis provides slow but continuous ultra-
ﬁltration. This might be an advantage because it might
imply an improved quality of life for patients to be
allowed a relatively liberal dietary intake of salt,
potassium, phosphate, protein, and ﬂuid. However, in
the opinion of most clinicians, ﬂuid overload is thought
to be more common in PD than in HD patients. In
contrast to this widespread belief, most studies com-
paring peritoneal versus hemodialysis patients ﬁnd that
ﬂuid overload is similar in both modalities.16-18 In
other studies, ﬂuid overload was more expressed in PD
versus HD patients. In one cross-sectional study of 76
prevalent patients (43 HD and 33 PD), the OH/ECW
ratio assessed by the bioimpedance spectroscopy
device was signiﬁcantly higher in PD patients com-
pared with post-HD patients.19 In another cross-
sectional study of 104 prevalent patients, FO was
even slightly more expressed in PD compared with
pre-HD.20 The relationship between ﬂuid status as
estimated by bioimpedance analysis and plasma albu-
min is different between PD and HD patients.
Although worsening of ﬂuid status as determined by
BIA was correlated strongly to a reduced plasmaalbumin level in both dialysis modalities, the associa-
tion was much stronger in PD patients.21
To date, it has not been clariﬁed why maintenance
of euvolemia seems to be less easy in peritoneal
dialysis as compared with HD. A lower compliance
rate with dietary salt and ﬂuid restriction has been
suggested, because thirst is more common in PD.22
Diabetes further aggravates thirst distress in PD
patients, explaining the increased rate of FO in diabetic
PD patients. Furthermore, although HD patients nor-
mally make routine visits of three times a week and
have their ﬂuid volume and dry weight controlled,
stable PD patients make less than one monthly contact
with the health professionals.
The 24-hour sodium removal was higher in CAPD
versus automatic PD (APD) patients, and there was a
trend toward better hypertension control in the CAPD
group.23 This may result in a difference in volume
status. However, no reliable data are available to
support the presence of a difference in ﬂuid status
between APD and CAPD. In an observational, cross-
sectional study of 158 prevalent patients (90 CAPD, 68
APD), there was no difference in the extracellular ﬂuid
volume (ECFE)/TBW ratio between CAPD (51.8%)
and APD (51.9%) patients (P ¼ .929).24 In another
cross-sectional study of 200 prevalent patients assessed
by bioimpedance spectroscopy, there was no difference
between CAPD and APD in ECF volume, height-
adjusted ECF volume, or the ECFV/TBW ratio.25
CAPD was shown to be superior to APD in evaluation
of left ventricular mass index and ultraﬁltration.
CLINICAL CONSEQUENCES OF FLUID STATUS IN PD
Fluid overload in peritoneal dialysis patients is asso-
ciated with mortality, particularly CV mortality.26,27
The overhydration index as measured by bioimpedance
spectroscopy was an independent predictor of mortality
when body mass index and lean tissue index were
included in a multivariate model.27 In a cross-sectional
study, ﬂuid overload as assessed by bioimpedance was
an independent predictor of all-cause mortality and
technique failure in CAPD patients.11 In a retrospective
study of 227 incident PD patients, ECF/intracellular
ﬂuid (ICF) was a strong predictor of survival, with a
relative risk of death of 1.4 for every increment of
0.1 in the ECF/ICF value28 (Fig. 1).
Hypervolemia, identiﬁed by the inferior vena cava
index, decrease of inferior vena cava diameter on deep
inspiration (collapsibility index), and anemia contrib-
uted independently to left ventricular geometry in
CAPD patients.29 PD patients with ﬂuid overload tend
to have increased left ventricular mass index, left
ventricular end-diastolic dimension, left ventricular
end-systolic dimension, and decreased left ventricular
ejection fraction and fractional shortening.30 Sustained
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associated with a reduced incidence and regression of
left ventricular hypertrophy.31 In randomized open-
label studies, a reduction of ﬂuid overload resulted in a
signiﬁcant reduction in left ventricular mass, suggest-
ing that left ventricular hypertrophy is modiﬁable
by improving volume control in peritoneal dialysis
patients.32,33 Fluid overload was related to diastolic
dysfunction, a sensitive and independent indicator of
future major adverse cardiovascular event (MACE) in
PD patients.34
High N-terminal pro-brain natriuretic peptide (NT pro
BNP) and cardiac troponin (cTNT) levels, reﬂecting left
ventricular dysfunction and ﬂuid overload, were asso-
ciated with sudden cardiac death.35 Additional ﬂuid
removal and strict volume control improved the BNP
level in incident hypertensive dialysis patients.36
Indices of volume are signiﬁcant predictors of new-
onset heart failure.37 Apart from MACE and mortality,
ﬂuid overload also is related closely to signiﬁcant
comorbidity and quality of life in PD patients. Uncon-
trolled hypertension and increased inﬂammatory
markers are more common in PD patients with ﬂuid
overload than in those without. Fluid overload also has
been associated with sleep apnea and nutritional status,
with a lower nutritional index and more frequent
malnutrition in those with FO.
Although the ECW content in hypertensive dialysis
patients is signiﬁcantly higher in general than in normo-
tensive dialysis patients, a wide variability in blood
pressure regardless of the degree of hydration status has
been observed in PD patients.38 In an observational
prospective cohort study, a signiﬁcant increase in ﬂuid
volume was not linked to a signiﬁcant increase in blood
pressure. Rather, the change in the total peripheral
resistance was found to be the most important determi-
nant of the extent to which increased ﬂuid volume
affected blood pressure.39 In the Brazilian PD (BrazPD)
cohort, edema control improved hypertension.40 Strict
volume control by dietary salt restriction and ultraﬁltra-
tion decreased mean blood pressure from 138.4  29.9
and 86.3  16.8 to 114.9  32.3 and 74.7  18.3 mm
Hg, respectively, in a 10-year follow-up study.41 In
addition, ﬂuid overload disrupts circadian variation of
blood pressure, a common ﬁnding in PD patients.
Reduced blood pressure variation was associated with
left ventricular mass index42,43 in PD patients. Patients
with chronic ﬂuid overload tend to have increased mean
carotid artery intima-media thickness.30
Bioimpedance spectroscopy–based ﬂuid overload
was an independent predictor for technique failure
and peritonitis in CAPD patients.11 In a randomized
controlled trial of 41 patients with diabetic nephrop-
athy with end-stage renal disease, icodextrin increased
technique survival by improving body ﬂuid manage-
ment over a 2-year follow-up period.44 Strict volumecontrol by dietary salt restriction and ultraﬁltration led
to a better technique survival during the ﬁrst 3 years,
but not after 5 years in a 10-year follow-up study.41
Fluid overload has been associated with an
increased duration of hospitalizations.45 Longitudinal
changes in the cardiothoracic ratio for 12 months on
routine chest radiographs were an independent predic-
tor of hospitalization-free survival.46
Because volume depletion has been linked to acute
kidney injury and a rapid decrease of residual renal
function (RRF), some have advocated mild ﬂuid overload
for preservation of residual renal function. According to
the reported data, however, both overhydration and
dehydration were associated with residual renal function
decrease, whereas maintaining adequate volume status
was shown to aid with RRF preservation.32,33 Changes in
residual renal function and ECW/TBW as measured by
bioimpedance spectroscopy in 237 adult patients who had
paired baseline and serial 12 monthly measurements
showed that increased ECW/TBW in PD patients was
not associated with preservation of RRF, whereas incre-
ments or decrements in ECW/TBW were not associated
with preservation or reduction in RRF.47,48 A threshold
value of optimal hydration to preserve residual renal
function needs to be elucidated.DRIVING FACTORS OF FLUID STATUS IN PD
PATIENTS
The ﬂuid status of PD patients can be inﬂuenced by
patient-related and by PD-related factors (Fig. 2).
Residual Renal Function
Residual renal diuresis was not related to ﬂuid status as
assessed by bioimpedance measurement in a large
observational cohort of prevalent European PD
patients.10 Renal clearance but not urinary volume
determined ﬂuid status in a US-based cohort,24
whereas in a Chinese prevalent cohort, less urinary
output was associated with overhydration.11 In incident
PD patients, urinary output was associated with ﬂuid
status in the univariate, but not in the multivariate,
analysis (1,834  900 versus 1,601  752 versus
1,492  734 mL/d, respectively, in the dehydrated,
normohydrated, and overhydrated patients).3 This
absence of a consistent relation between urinary output
and hydration status can be explained by different
factors. First, ﬂuid status is determined by the balance
between what goes out and what goes in. The output is
determined not only by urinary production, but also by
sweating, stools, and, in PD patients, achieved
ultraﬁltration. The input is determined by the ﬂuid
intake, and thus indirectly by salt intake and control of
serum glycemia. For patients with substantial urinary
output, it can be tempting to have unrestricted free
Figure 1. Consequences of fluid overload in PD patients. CHF, congestive heart failure; LVDD, left ventricular
diastolic dysfunction; LVH, left ventricular hypertrophy; PAH, pulmonary arterial hypertension; intima media
thickness (IMT).
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problematic when residual diuresis eventually starts to
decrease. Second, it has been argued that patients
should be kept slightly overhydrated to preserve
residual renal function because this has been associatedFigure 2. Modifiable and nonmodifiable factors inwith improved outcomes. However, retrospective
observational data with their inherent methodologic
limitations48 seem to indicate that an increased ECW/
TBW ratio was not associated with preservation of
residual renal function.47 Even anuric patients canfluencing fluid status. BMI, body mass index.
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role of blockers of the renin-angiotensin-aldosterone
system axis. A recent Cochrane analysis identiﬁed 6
open-label studies on this topic.50 Long-term (412
mo) use of renin-angiotensin-aldosterone system
blocking agents was associated with better preservation
of residual renal function in patients on peritoneal
dialysis as compared with other antihypertensive drugs.
There was insufﬁcient evidence to form a preference
between angiotensin-receptor blockers and angiotensin-
converting enzyme inhibitors.Salt and Fluid Intake
Hyperosmolarity is a main driver of thirst and thus of
water intake. Hyperosmolarity in PD patients can be
caused by, among other factors, salt intake or poor
glycemic control. Based on physiology studies, increasing
sodium intake will result in a (temporary) increase in total
body water, especially in the extracellular compartment.
Recently, nonosmotic storage of salt in the skin has been
unraveled as a mechanism used by the body to avoid ﬂuid
overload by salt intake.51 However, this mechanism also
explains the well-established long lag time between the
start of a sodium-decreasing strategy and the clinical
consequences such as decreased blood pressure because
the stored salt gradually is released again in the circulation.
As long as residual urinary output is maintained, either
spontaneously or by using diuretics, the kidney will
compensate the salt and ﬂuid overload by inducing
pressure diuresis. As residual renal function decreases,
total salt removal also will decrease,52 and might result in
ﬂuid overload. A high salt intake also will induce changes
in the peritoneal membrane that might jeopardize proper
peritoneal ultraﬁltration.53 Restriction in salt intake results
in better volume and blood pressure control in PD
patients.54 In a Cochrane review, salt restriction in patients
with advanced chronic kidney disease was associated with
improved blood pressure control.55
Poor glycemic control also will result in hyper-
osmolarity. Diabetes therefore has been associated with
increased odds of overhydration both in prevalent as
well as in incident patient cohorts.3,10,24 Because
hypertonic exchanges induce hyperglycemia,56 this
might explain why patients using hypertonic exchanges
remain overhydrated in observational studies.10,24 In
addition, use of hypertonic bags ampliﬁes sodium
sieving, resulting in more removal of free water but
not of sodium, thus contributing to the hyperosmolarity
and ﬂuid overload.57 Of note, hyperglycemia might
induce hyperinsulinism, which in turn will enhance
tubular sodium reabsorption. Although use of hyper-
tonic exchanges has been associated with ﬂuid overload
in prevalent patients, a randomized trial to assess the
use of glucose-sparing regimens concluded that patients
on the glucose-sparing regimen had an increased riskfor extracellular volume expansion despite an overall
improvement of glycemic control.58
Besides the direct effects through hypertonicity,
chronic hyperglycemia also leads to changes in the
peritoneal membrane such as neo-angiogenesis, leading
to ultraﬁltration failure.59 At least in animal models,
correcting hyperglycemia results in avoidance of these
diabetiform alterations of the peritoneal membrane.60Inﬂammation and Nutritional Status
In general, PD patients tend to have a lower lean tissue
mass and a higher fat tissue mass than the healthy
reference population.16 Because water associated with
fat tissue is nearly exclusively extracellular, and because
lean tissue mass is associated with intracellular water,
the increased ECW/TBW ratio in dialysis patients thus
partly could be artiﬁcial and unrelated to true ﬂuid
overload. In the BRAZPD cohort, an increase of body
mass index over time was associated with ﬂuid over-
load, but also signs of wasting.61
There is an association between overhydration on the
one hand and hypoalbuminemia and inﬂammation on
the other hand.11 Fluid overload has been associated
with both hypoalbuminemia10,11,24 and low hemoglobin
level.10 Although it is tempting to speculate that these
observations are caused by dilution, there was also an
association with C-reactive protein levels and protein
energy wasting, pointing out that inﬂammation also
could be the common denominator. Demirci et al30
showed an association between height-adjusted ECW
and serum C-reactive protein levels. Interestingly, endo-
toxemia62 and peritoneal protein clearance63 also have
been associated with signs of ﬂuid overload, inﬂamma-
tion being the most likely common underlying factor.
Although hypoalbuminemia is a hallmark of ﬂuid
overload in PD patients, this overhydration is not
associated with increased plasma volume, and accord-
ingly cannot be attributed merely to dilution. Also of
interest in kwashiorkor, there is a missing link between
overhydration and hypoalbuminemia. For several rea-
sons, it is plausible that disturbance of the glycocalix
function, whether or not by inﬂammation, might cause
the capillaries to become more leaky, leading to
hypoalbuminemia and interstitial edema.64
In addition, endothelial dysfunction as assessed by
ﬂow-mediated dilatation has been linked to ﬂuid over-
load in CAPD patients.38 Flow-mediated dilatation-
assessed endothelial dysfunction, sex, serum albumin,
and FO were independent determinants of edema status
in PD patients.65Small-Solute Transport
The concept that fast transport status is linked to
overhydration is well established in the minds of many
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because fast transporters have a rapid dissipation of
their glucose gradient, and thus negative ultraﬁltration
during longer dwells. Therefore, for fast transporters
short dwells are recommended,66 and APD, with its
short dwells, might lead to better outcomes for this
patient group.67 In observational trials,10,24 ﬂuid over-
load is slightly higher in fast transporters compared
with other transport categories, but with a wide range,
pointing out that other factors, such as adapted pre-
scription regimen and dietary intake, are at least as
important. To underline the impact of prescription,
ﬂuid overload was highest in patients in whom the
transport status was unknown,10 and in whom, by
consequence, the prescription could not be adapted to
transport status. It often is neglected that an inapt
prescription also can cause overhydration in slow
transporters. Too short dwells can induce sodium
sieving in slow transporters, and thus lead to removal
of free water but not of sodium, resulting in ﬂuid
retention.68 Adaptation of the dwell length to the
transport status of the patient is thus a necessity to
maintain normohydration.
Fast transport status can be caused by inﬂammation,
which in itself is linked to overhydration. In incident
patients, even before the start of PD, fast transporters
tended to be more ﬂuid overloaded than other transport
categories.3 This underscores that there are non–PD-
related common aspects to overhydration and fast
transport status, most likely inﬂammation.Impact of Dialysis Solutions
Since the ﬁrst introduction of biocompatible solutions
there has been a signal that they resulted in lower
ultraﬁltration as compared with nonbiocompatible ones.
This observation was against expectations because the
lower glucose degradation product (GDP)-containing
solutions, and especially the bicarbonate-based ones,
have been associated with lower vascular recruitment
in rat models.69 A recent Cochrane review70 identiﬁed 36
eligible studies on this topic, including a total of 2,719
patients. Overall, the study quality was rather low
because allocation methods and concealment generally
were incompletely reported. The use of neutral pH–low
GDP PD solutions resulted in greater urine output and
higher residual renal function when used for longer than
12 months. There was a trend for decreased ultraﬁltration
after a 4-hour dwell when using low-GDP versus
conventional solutions.71-73 This decreased ultraﬁltration
also was present when evaluated over a 3-month period,
but was no longer present when analyzed over 12- and
24-month periods of evaluation. More recently, Szeto
et al74 showed in a randomized study that low-GDP
solutions induced less ultraﬁltration and more ﬂuid
accumulation in the initial stage, but not in the longerterm, whereas Lichodziejewska-Niemierko et al75 found
overhydration and lower ultraﬁltration with low-GDP
solutions even after 24 months.
In the Cochrane review by Cho et al,70 prescription
of icodextrin was associated with improved peritoneal
ultraﬁltration and mitigated uncontrolled ﬂuid over-
load. Although the use of icodextrin for the long dwell
increases ultraﬁltration, especially in fast transporters,
the effects on the residual renal function can be
variable, depending on the underlying ﬂuid status of
the patient.32,33 The impact on ﬂuid status also can
be variable, depending on adherence to dietary
restrictions.CAPD Versus APD
Observational studies have shown that there is no
difference in sodium removal or volume control in
patients on APD versus CAPD.10,24 However, in both
of these cohorts, APD was performed with a low
number of cycles, avoiding too short dwell times and
sodium sieving. Indeed, other studies clearly have
shown that too short dwells (and too high a number
of cycles) are associated with decreased sodium
removal.76 This is especially so in patients with
membranes with slower transport characteristics.66ASSESSMENT OF FLUID STATUS
Different methods can be used to assess the ﬂuid status
of the patient. As described in the introduction, it is
important to realize that each method targets determi-
nation of ﬂuid in (a) speciﬁc compartment(s). There is
a need for formal assessment of ﬂuid status because
clinical observation alone is insufﬁcient to correctly
identify minor deviations from normohydration. Clin-
ical observation has a high speciﬁcity but a low
sensitivity for overhydration, and up to 30% of patients
who are labeled as normohydrated appear to be over-
hydrated when a formal assessment is performed.3Serum Biomarkers
BNP is used as a prognostic indicator for mortality, but
also has been put forward as a marker of ﬂuid
status.77,78 It is important to realize that BNP mainly
reﬂects ﬁlling pressure of the left atrium, and thus
cardiac congestion. As such, BNP reﬂects a mix of
cardiac dysfunction and circulating volume overload.
BNP also partly is cleared by dialysis and to a small
extent by the kidneys, and this might bias the inter-
pretation of values over time and cause an absence of a
clearly deﬁned reference range.79 As a consequence, in
hemodialysis, the performance of BNP as a marker of
ﬂuid status has been found to be poor.80,81 In PD
patients, it has been found to be a good reﬂection of
Fluid overload in PD 49right ventricular end-diastolic pressure,82 but proof of
its clinical usefulness is limited.83Lung Ultrasound
Lung ultrasound can be used to assess the extravascular
water content of the lungs. It is based on a semiquantitative
appreciation of the presence of reﬂections (called comets)
observed during an ultrasound examination of the lungs.
Accordingly, the technique merely reﬂects pulmonary
wedge pressure,84 and thus left ventricular preload and
circulating volume in relation to cardiac function rather
than ﬂuid status per se. The technique has been used in
hemodialysis85 and peritoneal dialysis15 patients. In the
latter study, lung congestion as assessed by lung ultra-
sound correlated strongly with left ventricular ejection
fraction, but not with the presence of peripheral edema,
indicating that indeed mainly circulating volume and
cardiac function are targeted by the technique. Paudel
et al86 showed that bioimpedance, BNP, and lung ultra-
sound provided different information, whereby BNP and
lung ultrasound mainly indicated left ventricular failure.
Siriopol et al26 associated lung ultrasound with mortality in
hemodialysis patients, but this was a cross-sectional non-
interventional trial, and thus it is very likely that pulmo-
nary congestion is just a consequence of underlying heart
failure, being the true driving cause of worse outcome.Bioimpedance Measurement
Bioimpedance analysis (BIA) uses a ﬂow of electrical
current through the body tissues to assess body
composition (Fig. 3) based on measured impedance,Figure 3. Principles of bioimpedancein itself a compound of resistance and reactance.
Single-frequency BIA uses only one frequency of
current, whereas bioimpedance spectroscopy uses mul-
tiple measurements at multiple frequencies. This
allows extrapolation (the theoretical) of impedance at
zero frequency (corresponding to extracellular water)
and at inﬁnite frequency (corresponding to total body
water). Resistance is related to water content, whereas
reactance is related to integrity of the cell membrane.
As such, bioimpedance allows not only assessment of
water content of the body, but also cell mass (intra-
cellular water). Different mathematic models can be
used to convert the measured impedance to values of
body composition. Two-compartmental models are
sufﬁcient for estimating fat mass, but three-
compartmental models perform better for estimation
of ﬂuid status.87 Each of these models has to be
calibrated and validated in a speciﬁc population with
a speciﬁc relation between parameters of body compo-
sition as measured with a golden reference standard
and bioimpedance.88,89 The more characteristics
the patient has that deviate substantially from that of
the reference population, the greater the chance that the
bioimpedance measurement results will be less
reliable. As such, results always have to be interpreted
As such, results always have to be interpreted by also
taking clinical circumstances into account.
All models, however, presume that the body is
composed of 3 linked cylinders: the arm, the leg, and
the trunk. Because resistance is related inversely to the
diameter of the cylinder, the arm and the leg will
contribute the most (490%) to the measured impe-
dance, whereas the trunk will have only a minorand bioimpedance spectroscopy.
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a very low sensitivity to pick up isolated pulmonary
congestion in heart failure. For the same reason, the
presence of peritoneal dialysis ﬂuid does not impact the
measurement substantially, although there is some
debate on this. Although BIA is an easy-to-perform,
noninvasive technique, it is important that the measure-
ment is performed according to a standardized proce-
dure, with attention to electrode position and contact.
Bioimpedance has been linked to mortality both in
hemodialysis as in peritoneal dialysis patients.27,90 BIA
has good reproducibility, and therefore, in longitudinal
studies, BIA is good to identify changes in ﬂuid status
that otherwise might not be clinically identiﬁable
(eg, a loss of muscle mass caused by anorexia, in
which total body weight remains unchanged because of
gradual ﬂuid accumulation). Luo et al91 showed that
BIA can help guide ﬂuid control in PD patients.
BIA allows assessment of ECW, ICW, and TBW, but
for the interpretation of ﬂuid status, it is important that the
number can be interpreted taking into account the body
size of the patient. The use of the ECW/TBW or ECW/
ICW ratio can lead to confusion because an increasing
ECW/TBW ratio can be both a signal of increasing ECW
(and thus overhydration), or of decreasing ICW (and thus
malnutrition/sarcopenia). Some have advocated the use of
ECW/height for this reason. However, even with the
latter there might be confusion regarding patients with
increasing fat mass because fat mass is associated
with extracellular water. An alternative approach has
been introduced by Chamney et al,89 who modeled
the amount of water that should be present in the
different compartments according to body composition
theory, and designated the difference (either an excess
or deﬁcit) with the actually measured values as ﬂuid
overload.STRATEGIES TO ACHIEVE EUVOLEMIA IN PD
PATIENTS
Because there are different causes of ﬂuid overload in
peritoneal dialysis patients, it is clear that avoiding
ﬂuid overload or restoring euvolemia can be
achieved only by taking many different aspects into
account.
A ﬁrst step is to increase awareness of the problem,
and the understanding that clinical assessment (absence
of edema, blood pressure) can be insufﬁcient to detect
the presence of ﬂuid overload in the patient.3,18
Regular formal assessment of ﬂuid status thus probably
is mandatory. Luo et al91 showed that regular determi-
nation of overhydration by use of bioimpedance
facilitates volume control.
Several strategies can be used to achieve euvolemia
in the short term.Diuretics can be used to increase urinary output of
water and salt. However, it should be realized that the
enhanced excretion of salt with diuretics is only short-
lived and that after a couple of days, a new equilibrium
will be reached. The use of diuretics also might have a
negative impact on residual renal function.
Use of hypertonic exchanges can increase the ultra-
ﬁltration volume. The impact on residual renal function
and volume balance, however, can be variable, depend-
ing on the underlying ﬂuid status and cardiac function
of the patient. There is also the risk of enhanced ﬂuid
intake because both hyperglycemia associated with
poor glycemic control with hypertonic bags, similar
to hypernatremia associated with sodium sieving, can
increase thirst. It also should not be neglected that use
of hypertonic exchanges will lead to more rapid
deterioration of peritoneal membrane function, and
potentially also of residual renal function.
Icodextrin can be used to increase ultraﬁltration
volume in the long dwell. In a Cochrane review, use
of icodextrin appeared to improve ﬂuid status in PD
patients.70 However, most patients can be treated with
nonhypertonic glucose solutions if their dwell time is
adapted appropriately to their small-solute transport
rate.66
Restriction of salt and ﬂuid intake is probably the
most effective way to avoid ﬂuid overload. In this
regard, a strategy whereby dietary restriction of sodium
and ﬂuid intake are started early and combined with an
individualized prescription of dwell time might prove
to be worthwhile. As residual renal function decreases,
icodextrin can be added to enhance ultraﬁltration
volume. The need for hypertonic exchanges should
be delayed as long as possible to avoid more accel-
erated deterioration of the peritoneal membrane and
residual renal function. Where available and afford-
able, low-GDP solutions might add to protection of
residual renal function. Such a strategy currently is
being tested in a large observational international trial
of incident PD patients.3
The most frustrating observation on ﬂuid manage-
ment in PD patients is that there are technical limits on
what reasonably can be achieved with the technique.
Adequate and timely preparation of the patient for an
eventual transfer to hemodialysis therefore also should
be part of a well-established program to maintain
euvolemia.
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